A randomized, double-blind, placebo-controlled, first-in-human single ascending dose, multiple ascending dose, and food effect study to evaluate the safety, tolerability, and pharmacokinetic profile of FM101 in healthy volunteers

被引：0

作者：

Ha, Seon-Ah ^{[1
]}

Kim, Mi Ri ^{[1
]}

Kang, Saehan ^{[1
]}

Yu, Mira ^{[1
]}

Park, Chong-Woo ^{[1
]}

Lee, Jiyoun ^{[1
]}

Kang, Jiyeon ^{[1
]}

Kim, Ji-Young ^{[1
]}

Seo, Seong Wook ^{[1
]}

Son, Seohyun ^{[1
]}

Cho, Hyeon Deok ^{[1
]}

Lee, Hyuk Woo ^{[1
]}

Jeong, Lak Shin ^{[1
,2
]}

机构：

[1] Future Med Co Ltd, Seongnam, Gyeonggi Do, South Korea

[2] Seoul Natl Univ, Coll Pharm, Seoul, South Korea

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI096

引用

页码：S446 / S447

页数：2

共 50 条

[1] A Double-Blind, Randomised, Placebo-Controlled, Multiple Ascending Dose Study to Investigate Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Zamicastat, in Healthy Male Volunteers
Magalhaes, L.
Rocha, F.
Falcao, A.
Gama, H.
Soares-Da-Silva, P.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[2] A First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study To Assess the Safety and Tolerability of LFF571 in Healthy Volunteers
Ting, Lillian S. L.
Praestgaard, Jens
Grunenberg, Nicole
Yang, Jenny C.
Leeds, Jennifer A.
Pertel, Peter
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5946 - 5951
[3] A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF OCR-002 IN HEALTHY VOLUNTEERS
Jochelson, P.
van de Wetering, J. L.
Bornstein, J.
Resler, M.
Anderson, K.
JOURNAL OF HEPATOLOGY, 2011, 54 : S70 - S70
[4] A Double-blind, Placebo-controlled, Randomized, Single Ascending, and Multiple Dose Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Dose Isomyosamine Capsules in Healthy Adult Subjects
Brager, Jenna
Chapman, Chris
Dunn, Leonard
Kaplin, Adam
DRUG RESEARCH, 2023, 73 (02) : 95 - 104
[5] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Ascending Multiple Oral Doses of CC 930 in Healthy Volunteers
Kong, Linghui
Ye, Ying
Liu, Liangang
Reyes, Josephine
Wan, Yuntao
Wu, Anfan
Lau, Henry
Laskin, Oscar
JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1343 - 1343
[6] A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose and Food Effect Study to Evaluate the Tolerance, Pharmacokinetics of Jaktinib, a New Selective Janus Kinase Inhibitor in Healthy Chinese Volunteers
Liu, Jingrui
Lv, Binhua
Yin, Hewen
Zhu, Xiaoxue
Wei, Haijing
Ding, Yanhua
FRONTIERS IN PHARMACOLOGY, 2020, 11
[7] A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor
Barry Gidal
Graham Blakey
Bola Tayo
Gilmour Morrison
CNS Drugs, 2018, 32 : 1053 - 1067
[8] A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Taylor, Lesley
Gidal, Barry
Blakey, Graham
Tayo, Bola
Morrison, Gilmour
CNS DRUGS, 2018, 32 (11) : 1053 - 1067
[9] A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel spiroindolone KAE609, to assess the safety, tolerability and pharmacokinetics in healthy adult volunteers
Joel Leong
Ruobing Li
Jay Prakash Jain
Gilbert Lefèvre
Baldur Magnusson
Thierry Diagana
Peter Pertel
Malaria Journal, 13 (Suppl 1)
[10] A single-center, randomized, placebo-controlled, double-blind study to evaluate the safety, tolerability, and pharmacokinetics of multiple-ascending doses of pridopidine in healthy volunteers
Osterberg, O.
Ivkovic, J.
Sundgreen, C.
Muglia, P.
Prang, A.
Darpo, B.
NEUROTHERAPEUTICS, 2013, 10 (01) : 175 - 175

← 1 2 3 4 5 →